Islet Management’s GeneDx Holdings WGS Stock Holding History

Islet Management’s Portfolio WGS Stock Details WGS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-6,308	Closed	-$441K	–	265
2021 Q3	$441K	Buy	+6,308	New	+$2.17M	0.01%	188

Other funds holding WGS

Blackstone Inc New York $39B AUM 18.55% 1-Year Est. Return

Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return

Casdin Capital New York $2B AUM 147.21% 1-Year Est. Return

Corvex Management New York $3.27B AUM 38.53% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

OIM

Oracle Investment Management Greenwich, Connecticut $168M AUM 42.86% 1-Year Est. Return

Third Point New York $4.68B AUM 37.3% 1-Year Est. Return

Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return

Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

Islet Management's WGS Position: Q2 2022 in Review

Islet Management sold out of GeneDx Holdings (WGS) in Q2 2022, closing a stake of 25,733 shares — an estimated $2.61M sold.

Islet Management first reported a position in WGS in Q1 2021 and held it in 5 quarters. The position peaked at $9.87M in Q3 2021. 111 funds tracked by Wall St. Rank hold WGS as of Q2 2022.

Islet Management reported no remaining GeneDx Holdings position as of Q2 2022 after selling out during the quarter.
Islet Management sold 25,733 GeneDx Holdings shares in Q2 2022, an estimated $2.61M.
Islet Management first reported a position in GeneDx Holdings in Q1 2021 and held it in 5 quarters.
Islet Management's GeneDx Holdings position peaked at $9.87M in Q3 2021.
111 funds tracked by Wall St. Rank held GeneDx Holdings as of Q2 2022.

Based on Islet Management's 13F filing for Q2 2022, filed 15 Aug 2022.